• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.

作者信息

González-Olmedo Carmen, García-Verdejo Francisco José, Reguera-Teba Antonio, Rosa-Garrido Carmen, López-López José Antonio, Díaz-Beltrán Leticia, García Patricia Mena, Luque-Caro Natalia, Gálvez-Montosa Fernando, Ortega-Granados Ana Laura, Ruiz-Sanjuan María, Cózar-Ibáñez Antonio, Sainz Juan, Marchal Juan Antonio, Camacho José, Del Palacio José Pérez, Fernández-Godino Rosario, Díaz Caridad, Sánchez-Rovira Pedro

机构信息

Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.

Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.

出版信息

Clin Transl Med. 2024 Jan;14(1):e1541. doi: 10.1002/ctm2.1541.

DOI:10.1002/ctm2.1541
PMID:38239072
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10797245/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/883c9cf9538c/CTM2-14-e1541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/36ed918dfc18/CTM2-14-e1541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/eb6fc8f1adc6/CTM2-14-e1541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/883c9cf9538c/CTM2-14-e1541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/36ed918dfc18/CTM2-14-e1541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/eb6fc8f1adc6/CTM2-14-e1541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e25/10797245/883c9cf9538c/CTM2-14-e1541-g003.jpg

相似文献

1
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.代谢组学特征作为可切除结直肠癌肝转移患者生存预测指标
Clin Transl Med. 2024 Jan;14(1):e1541. doi: 10.1002/ctm2.1541.
2
Outcomes Following Treatment with FOLFOX for Patients with Resectable or Potentially Resectable Metastatic Colorectal Cancer: A Population-based Cohort Study.可切除或潜在可切除转移性结直肠癌患者接受 FOLFOX 治疗的结果：一项基于人群的队列研究。
Clin Oncol (R Coll Radiol). 2023 Mar;35(3):188-198. doi: 10.1016/j.clon.2022.12.009. Epub 2023 Jan 5.
3
Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?对于可切除的结直肠癌肝转移患者，新辅助化疗与辅助化疗联合手术相比，是否存在生存获益？
World J Surg. 2009 May;33(5):1028-34. doi: 10.1007/s00268-009-9945-1.
4
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.可切除结直肠肝转移患者的系统化疗联合或不联合西妥昔单抗：New EPOC 随机对照试验。
Lancet Oncol. 2014 May;15(6):601-11. doi: 10.1016/S1470-2045(14)70105-6. Epub 2014 Apr 7.
5
Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis.术前和术后FOLFOX化疗对可切除性结直肠癌肝转移患者的影响。
J Gastrointest Cancer. 2014 Sep;45(3):298-306. doi: 10.1007/s12029-014-9594-y.
6
Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer.结直肠癌同步可切除或不可切除肝转移患者肝淋巴结转移对生存的影响。
Tech Coloproctol. 2013 Feb;17(1):51-7. doi: 10.1007/s10151-012-0881-y. Epub 2012 Aug 31.
7
Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial).S-1、奥沙利铂联合贝伐单抗用于结直肠癌肝转移新辅助化疗的II期试验（N-SOG 05试验）
Jpn J Clin Oncol. 2017 Jul 1;47(7):597-603. doi: 10.1093/jjco/hyx048.
8
[Colorectal cancer].[结直肠癌]
Gan To Kagaku Ryoho. 2011 Aug;38(8):1252-5.
9
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.卡培他滨、奥沙利铂加贝伐珠单抗作为未经选择的直接手术切除的高危结直肠肝转移患者的围手术期治疗的多中心研究。
Ann Oncol. 2011 Sep;22(9):2042-2048. doi: 10.1093/annonc/mdq714. Epub 2011 Feb 1.
10
Simultaneous surgery for primary colorectal cancer and metastatic lesions?原发性结直肠癌与转移灶的同期手术？
Scand J Gastroenterol. 2012 Mar;47(3):269-76. doi: 10.3109/00365521.2012.640824. Epub 2012 Jan 16.

引用本文的文献

1
New Frontiers of Biomarkers in Metastatic Colorectal Cancer: Potential and Critical Issues.转移性结直肠癌生物标志物的新前沿：潜力与关键问题
Int J Mol Sci. 2025 May 30;26(11):5268. doi: 10.3390/ijms26115268.
2
Assessment of Untargeted Metabolomics by Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry to Define Breast Cancer Liquid Biopsy-Based Biomarkers in Plasma Samples.采用亲水作用液相色谱-质谱联用技术进行非靶向代谢组学评估，以鉴定血浆样本中基于液体活检的乳腺癌生物标志物。
Int J Mol Sci. 2024 May 7;25(10):5098. doi: 10.3390/ijms25105098.

本文引用的文献

1
Metabolic reprogramming in colorectal cancer: regulatory networks and therapy.结直肠癌中的代谢重编程：调控网络与治疗
Cell Biosci. 2023 Feb 8;13(1):25. doi: 10.1186/s13578-023-00977-w.
2
The Application of Metabolomics in Recent Colorectal Cancer Studies: A State-of-the-Art Review.代谢组学在近期结直肠癌研究中的应用：最新综述
Cancers (Basel). 2022 Jan 30;14(3):725. doi: 10.3390/cancers14030725.
3
Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis.
循环代谢物作为一个超越肿瘤生物学的概念，决定了结直肠癌肝转移切除术后的疾病复发。
HPB (Oxford). 2022 Jan;24(1):116-129. doi: 10.1016/j.hpb.2021.06.415. Epub 2021 Jun 24.
4
Xanthine oxidoreductase promotes the progression of colitis-associated colorectal cancer by causing DNA damage and mediating macrophage M1 polarization.黄嘌呤氧化还原酶通过引起 DNA 损伤和介导巨噬细胞 M1 极化促进结肠炎相关结直肠癌的进展。
Eur J Pharmacol. 2021 Sep 5;906:174270. doi: 10.1016/j.ejphar.2021.174270. Epub 2021 Jun 24.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Hepatic metastasis from colorectal cancer.结直肠癌肝转移
J Gastrointest Oncol. 2019 Dec;10(6):1274-1298. doi: 10.21037/jgo.2019.08.06.
7
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.人疾病中溶血磷脂酰胆碱代谢的最新综述
Int J Mol Sci. 2019 Mar 6;20(5):1149. doi: 10.3390/ijms20051149.
8
Role of diet and gut microbiota on colorectal cancer immunomodulation.饮食和肠道微生物群在结直肠癌免疫调节中的作用。
World J Gastroenterol. 2019 Jan 14;25(2):151-162. doi: 10.3748/wjg.v25.i2.151.
9
Taurocholic acid metabolism by gut microbes and colon cancer.肠道微生物对牛磺胆酸的代谢与结肠癌
Gut Microbes. 2016 May 3;7(3):201-15. doi: 10.1080/19490976.2016.1150414. Epub 2016 Mar 22.